Lead Product(s): Serelaxin
Therapeutic Area: Cardiology/Vascular Diseases Product Name: Undisclosed
Highest Development Status: Phase II Product Type: Peptide
Partner/Sponsor/Collaborator: CBL- Chemical and Biopharmaceutical Laboratories
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership February 02, 2021
This cooperation agreement designates CBL as the exclusive manufacturing partner for synthetic human relaxin-2 (GMP and non-GMP) and Relaxera as the exclusive sales executive partner for relaxin.